These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4005107)

  • 1. Antipyrine clearance in children from single saliva samples.
    Loft S; Haxholdt O; Døssing M
    Br J Clin Pharmacol; 1985 May; 19(5):698-700. PubMed ID: 4005107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method for determination of antipyrine clearance.
    Døssing M; Poulsen HE; Andreasen PB; Tygstrup N
    Clin Pharmacol Ther; 1982 Sep; 32(3):392-6. PubMed ID: 7105629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fever on antipyrine metabolism in children.
    Forsyth JS; Moreland TA; Rylance GW
    Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
    Harman AE; Priestly BG; Frewin DB
    Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
    Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
    Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of antipyrine kinetics by measurement in saliva.
    Fraser HS; Mucklow JC; Murray S; Davies DS
    Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of salivary concentration data to pharmacokinetic studies with antipyrine.
    Meffin PJ; Williams RL; Blaschke TF; Rowland M
    J Pharm Sci; 1977 Jan; 66(1):135-7. PubMed ID: 833730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-sample method for antipyrine clearance determination in rats.
    Pilsgaard H; Poulsen HE
    Pharmacology; 1984; 29(2):110-6. PubMed ID: 6473504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma.
    el-Yazigi A; Raines DA; Ali H; Sieck J; Ernst P; Dossing M
    Pharm Res; 1991 Feb; 8(2):269-72. PubMed ID: 2023880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of the one-sample method for determination of antipyrine clearance in elderly subjects.
    Jorquera F; Almar MM; González-Sastre M; Suarez I; González-Gallego J
    J Pharm Biomed Anal; 1996 Oct; 15(1):7-11. PubMed ID: 8895071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of isoniazid on antipyrine clearance in man.
    Grech-Belanger O; Belanger PM; Lachance J
    J Clin Pharmacol; 1983; 23(11-12):540-4. PubMed ID: 6662978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of famotidine, a new H2 receptor antagonist, on antipyrine clearance in healthy volunteers.
    Piersimoni F; Del Prete U; Jèzèquel AM; Orlandi F
    Pharmacol Res Commun; 1987 Feb; 19(2):183-90. PubMed ID: 3588653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased values of antipyrine clearance in type IV hyperlipoproteinemia.
    Bedeleanu D; Trif I; Lötsch JC; Cucuianu MP
    Med Interne; 1986; 24(3):183-90. PubMed ID: 3775212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antipyrine kinetics from saliva or plasma: influence of age.
    Jorquera F; Almar MM; Jimeno A; González-Sastre M; González-Gallego J
    J Pharm Biomed Anal; 1995 Aug; 13(9):1141-5. PubMed ID: 8573640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrene clearance in Indian villagers.
    Desai NK; Sheth UK; Mucklow JC; Fraser HS; Bulpitt CJ; Jones SW; Dollery CT
    Br J Clin Pharmacol; 1980 Apr; 9(4):387-94. PubMed ID: 7378255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
    van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.